Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Mark D McKenzie"'
Autor:
Steven Ngo, Ethan P. Oxley, Margherita Ghisi, Maximilian M. Garwood, Mark D. McKenzie, Helen L. Mitchell, Peter Kanellakis, Olivia Susanto, Michael J. Hickey, Andrew C. Perkins, Benjamin T. Kile, Ross A. Dickins
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Differentiation therapy induces the maturation and clearance of acute myeloid leukemia cells. Here, using a mouse model, the authors show that a specific lineage of mature leukemia-derived cells persists during remission and is responsible for diseas
Externí odkaz:
https://doaj.org/article/5f04ec10aa484e7aa4589412ec95bdf7
Autor:
Matthew P. McCormack, Sara Tomei, Olivia Stonehouse, Adrienne A. Hilton, Matthew E. Ritchie, Andrew Jarratt, Dawn S. Lin, Warren S. Alexander, Samir Taoudi, Mark D. McKenzie, Stephen L. Nutt, Jaring Schreuder, Ashley P. Ng, Shalin H. Naik, Ladina Di Rago, Daniela Amann-Zalcenstein, Jacob T. Jackson, Jessica E. Bolden, Carolyn A. de Graaf, Kirsten A. Fairfax, Luyi Tian
Publikováno v:
Nature Immunology. 21:1574-1584
A classical view of blood cell development is that multipotent hematopoietic stem and progenitor cells (HSPCs) become lineage-restricted at defined stages. Lin-c-Kit+Sca-1+Flt3+ cells, termed lymphoid-primed multipotent progenitors (LMPPs), have lost
Autor:
Ross A. Dickins, Benjamin T. Kile, Steven Ngo, Andrew C. Perkins, Mark D. McKenzie, Margherita Ghisi, Olivia Susanto, Michael J. Hickey, Helen Mitchell, Peter Kanellakis, Ethan P. Oxley, Maximilian M. Garwood
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Nature Communications
Nature Communications
Acute myeloid leukemia (AML) is a malignancy of immature progenitor cells. AML differentiation therapies trigger leukemia maturation and can induce remission, but relapse is prevalent and its cellular origin is unclear. Here we describe high resoluti
Autor:
Natasha Silke, Manfred Boehm, Amanda K. Ombrello, Ivona Aksentijevich, Deborah L. Stone, Tina Romeo, Marco J Herold, Laurens Wachsmuth, Christine Biben, Beverly K. Barham, Lin Liu, Andrew J. Gross, Sergio D. Rosenzweig, Patrycja Hoffmann, Natalia Sampaio Moura, Gustavo Gutierrez-Cruz, Daniel L. Kastner, Steven E. Boyden, Kristien J. M. Zaal, Anne K. Voss, Holly Anderton, Anne Jones, Hongying Wang, Tobias Kratina, John Silke, Michael J. Lenardo, James C. Mullikin, Kate E. Lawlor, David B. Beck, Mark D. McKenzie, Amanda Light, Anthony K. Shum, Jae Jin Chae, Massimo Gadina, Qing Zhou, Diep Chau, Gineth Pinto-Patarroyo, Hirotsugu Oda, Geryl Wood, Mary Blake, Nima Etemadi, Kristy Shield-Artin, Edwin D. Hawkins, Monique Stoffels, Cathrine Hall, Dan Yang, Wanxia Li Tsai, Hye Sun Kuehn, Natalia I. Dmitrieva, Seth L. Masters, Lixin Zheng, Andrew J. Kueh, Manolis Pasparakis, Najoua Lalaoui
Publikováno v:
Nature
Nature, vol 577, iss 7788
Nature, vol 577, iss 7788
Receptor Interacting Protein Kinase 1 (RIPK1) is a key regulator of innate immune signalling pathways. To ensure an optimal inflammatory response, RIPK1 is post-translationally regulated by well characterised ubiquitylation and phosphorylation events
Autor:
Matthew E. Ritchie, Kirsten A. Fairfax, Geyu Zhou, Mark D. McKenzie, Ladina Di Rago, Bruce S. Bochner, Erin C. Lucas, Carolyn A. de Graaf, Douglas J. Hilton, Warren S. Alexander, Tracey M. Baldwin, Jessica E. Bolden, Jeremy A. O'Sullivan, Jake Shortt
Publikováno v:
Journal of leukocyte biology
In recent years multi-parameter flow cytometry has enabled identification of cells at major stages in myeloid development; from pluripotent hematopoietic stem cells, through populations with increasingly limited developmental potential (common myeloi
Autor:
Tracy A. Willson, Cedric S. Tremblay, Margherita Ghisi, Mark D. McKenzie, Ioannis Aifantis, Grace Liu, Yifang Hu, Gordon K. Smyth, Ross A. Dickins, Kathryn G. Roberts, Seth Frietze, Oliver D. Le Grice, Martin A. Horstmann, Matthew T. Witkowski, Luisa Cimmino, Judith M. Boer, Charles G. Mullighan, Monique L. den Boer
Publikováno v:
The Journal of Experimental Medicine
Journal of Experimental Medicine, 214(3), 773-791. Rockefeller University Press
Journal of Experimental Medicine, 214(3), 773-791. Rockefeller University Press
Analysis of mouse and human B lineage acute lymphoblastic leukemia identifies evolutionarily conserved targets of the tumor-suppressive transcription factor IKAROS, implicating CTNND1 in leukemia maintenance.
Genetic alterations disrupting the t
Genetic alterations disrupting the t
Autor:
Daniela, Amann-Zalcenstein, Luyi, Tian, Jaring, Schreuder, Sara, Tomei, Dawn S, Lin, Kirsten A, Fairfax, Jessica E, Bolden, Mark D, McKenzie, Andrew, Jarratt, Adrienne, Hilton, Jacob T, Jackson, Ladina, Di Rago, Matthew P, McCormack, Carolyn A, de Graaf, Olivia, Stonehouse, Samir, Taoudi, Warren S, Alexander, Stephen L, Nutt, Matthew E, Ritchie, Ashley P, Ng, Shalin H, Naik
Publikováno v:
Nature immunology. 21(12)
A classical view of blood cell development is that multipotent hematopoietic stem and progenitor cells (HSPCs) become lineage-restricted at defined stages. Lin
Autor:
Mark D. McKenzie, Jaring Schreuder, Kirsten A. Fairfax, Andrew Jarrat, Jess Bolden, Matt McCormack, Sara Tomei, Matthew E. Ritchie, Ladina Di Rago, Adrienne A. Hilton, Daniela Zalcenstein, Jacob T. Jackson, Ashley P. Ng, Dawn S. Y. Lin, Warren S. Alexander, Shalin H. Naik, Luyi Tian, D J Hilton
Publikováno v:
Experimental Hematology. 76:e1-e2
A classical view of blood cell development is that multipotent haematopoietic stem and progenitor cells (HSPCs) become lineage-restricted at defined stages. The Lin–c-kit+Sca1+Flt3+ stage, termed lymphoid-primed multipotent progenitors (LMPPs), hav
Autor:
S. Jayakrishnan, Benjamin T. Kile, Michael J. Hickey, Maximilian M. Garwood, Olivia Susanto, S. Ngo, Andrew C. Perkins, Mark D. McKenzie, Ross A. Dickins, Margherita Ghisi, Ethan P. Oxley, Helen Mitchell
Publikováno v:
HemaSphere. 3:53-54
Autor:
Tracy A. Willson, Meinrad Busslinger, Yifang Hu, Thomas Trimarchi, Sarah A. Best, Matthew T. Witkowski, Luisa Cimmino, Stewart L Nutt, Ioannis Aifantis, Laura Tuohey, Hiromi Tagoh, Gordon K. Smyth, Ross A. Dickins, Mark D. McKenzie
Publikováno v:
Leukemia. 29:1301-1311
Activating NOTCH1 mutations occur in ~ 60% of human T-cell acute lymphoblastic leukemias (T-ALLs), and mutations disrupting the transcription factor IKZF1 (IKAROS) occur in ~5% of cases. To investigate the regulatory interplay between these driver ge